Source link : https://www.newshealth.biz/health-news/fda-rejects-mdma-assisted-therapy-for-ptsd/
The FDA declined to approve midomafetamine (MDMA) as an adjunct to psychotherapy for post-traumatic stress disorder (PTSD), calling for additional data, developer Lykos Therapeutics announced on Friday. “The FDA has requested that Lykos conduct an additional Phase 3 trial to further study the safety and efficacy of midomafetamine,” the company said. “Lykos plans to request […]
Author : News Health
Publish date : 2024-08-09 21:47:05
Copyright for syndicated content belongs to the linked Source.
Categories